Recent developments in C5/C5a inhibitors

Author： Proctor Lavinia M Woodruff Trent M Taylor Stephen M

ISSN： 1354-3776

Source： Expert Opinion on Therapeutic Patents, Vol.16, Iss.4, 2006-04, pp. : 445-458

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Recent developments in 5lipoxygenase inhibitors

By Julémont Fabien Dogné Jean-Michel Laeckmann Didier Pirotte Bernard Leval Xavier de

Expert Opinion on Therapeutic Patents, Vol. 13, Iss. 1, 2003-01 ,pp. : 1-13

Informa Healthcare

Access to resources Recommend Favorite

5-Lipoxygenase inhibitors: a review of recent developments and patents

By Pergola Carlo Werz Oliver

Expert Opinion on Therapeutic Patents, Vol. 20, Iss. 3, 2010-03 ,pp. : 355-375

Informa Healthcare

Access to resources Recommend Favorite

Recent developments in protein kinase C inhibitors

By Harris W. Wilkinson S. Nixon J.

Expert Opinion on Therapeutic Patents, Vol. 7, Iss. 1, 1997-01 ,pp. : 63-68

Informa Healthcare

Access to resources Recommend Favorite

The Changing Face of Hepatitis C: Recent Advances on HCV Inhibitors Targeting NS5A

Current Medicinal Chemistry, Vol. 22, Iss. 15, 2015-05 ,pp. : 1860-1879

Bentham Science Publishers

Access to resources Recommend Favorite

Human rhinovirus 3C protease inhibitors: recent developments

By Wang Q.M.

Expert Opinion on Therapeutic Patents, Vol. 8, Iss. 9, 1998-09 ,pp. : 1151-1156

Informa Healthcare

Access to resources Recommend Favorite